Geneva, Oct. 21 -- International Clinical Trials Registry received information related to the study (NCT07204392) titled 'Unveiling the Germline Predisposition to Myeloproliferative Neoplasms' on Sept. 24.
Study Type: Observational
Primary Sponsor: Fondazione IRCCS Policlinico San Matteo di Pavia
Condition:
Myeloproliferative Disease
Germline Mutation
Recruitment Status: Recruiting
Date of First Enrollment: June 27, 2022
Target Sample Size: 313
Countries of Recruitment:
Italy
To know more, visit https://clinicaltrials.gov/study/NCT07204392
Published by HT Digital Content Services with permission from Health Daily Digest....